Artelo Biosciences, Inc.
ARTL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,826 | -$9,289 | -$10,083 | -$7,437 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $818 | $1,020 | $2,458 | $1,531 |
| Change in WC | $937 | $703 | -$172 | -$242 |
| Other Non-Cash | -$279 | -$641 | -$211 | $7 |
| Operating Cash Flow | -$8,350 | -$8,207 | -$8,008 | -$6,141 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$481 | -$13,685 | -$13,224 | -$3,439 |
| Inv. Sales/Matur. | $8,250 | $17,192 | $16,182 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $7,769 | $3,507 | $2,958 | -$3,439 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $112 | $567 | $0 | $8,103 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $6,009 |
| Financing Cash Flow | $112 | $567 | $0 | $14,112 |
| Forex Effect | -$8 | $60 | -$224 | -$45 |
| Net Chg. in Cash | -$477 | -$4,073 | -$5,274 | $4,487 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,815 | $6,888 | $12,162 | $2,142 |
| End Cash | $2,338 | $2,815 | $6,888 | $6,629 |
| Free Cash Flow | -$8,350 | -$8,207 | -$8,008 | -$6,141 |